+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ipsen Group - logo

Ipsen is a global specialty-driven pharmaceutical group committed to discovering new solutions for targeted debilitating diseases. The company offers drugs in urology – oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology, and cardiovascular areas. Its products include Decapeptyl, Hexvix, Somatuline, NutropinAq and Dysport. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen S.A. is a subsidiary of Mayroy S.A.

Autoimmune Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2025

  • Report
  • April 2025
  • 500 Pages +
  • Global
From
Endometriosis - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Endometriosis - Global Drug Forecast and Market Analysis to 2030

  • Report
  • December 2021
  • 124 Pages
  • Global
From
Osteoporosis - Pipeline Review, H2 2020 - Product Thumbnail Image

Osteoporosis - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 375 Pages
  • Global
From
From
From
From
Renal Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Renal Cell Carcinoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pediatric Bladder Treatment Market Report 2025 - Product Thumbnail Image

Pediatric Bladder Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Esophageal Squamous Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Esophageal Squamous Cell Carcinoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 150 Pages
  • Global
From
Cerebral Palsy - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Cerebral Palsy - Global Clinical Trials Review, 2025

  • Clinical Trials
  • February 2025
  • 254 Pages
  • Global
From
Leucine-Rich Repeat Kinase (LRRK)-2 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Leucine-Rich Repeat Kinase (LRRK)-2 Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Botulinum Toxin - Global Strategic Business Report - Product Thumbnail Image

Botulinum Toxin - Global Strategic Business Report

  • Report
  • May 2025
  • 353 Pages
  • Global
From
Skin Cancer Drugs Market Report 2025 - Product Thumbnail Image

Skin Cancer Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
From
Modified Release Neurology Therapeutics - Product Thumbnail Image

Modified Release Neurology Therapeutics

  • Report
  • January 2024
  • 125 Pages
  • Global
From
Loading Indicator